Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for North Vista Hospital located at 1409 E Lake Mead Blvd, North Las Vegas, NV, 89030 & includes data from NPIs 1720037799, 1619050549
*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 10,408 | 9,608 | ||||||||||
Surgical | 766 | 732 | ||||||||||
Non Surgical | 9,642 | 8,876 | ||||||||||
Psychiatry & Mental Disorders | 4,449 | 4,282 | ||||||||||
General Medicine | 1,484 | 1,298 | ||||||||||
Cardiovascular | 1,191 | 1,018 | ||||||||||
Pulmonology | 836 | 758 | ||||||||||
Gastroenterology & Endocrinology | 640 | 580 | ||||||||||
Urology | 511 | 480 | ||||||||||
Neurology | 449 | 404 | ||||||||||
General Surgery | 291 | 273 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 267 | 261 | ||||||||||
Orthopedics | 155 | 135 | ||||||||||
Oncology & Hematology | 80 | 65 | ||||||||||
Dermatology | 20 | 20 | ||||||||||
Obstetrics & Gynecology | 16 | 15 | ||||||||||
Colorectal | 13 | 13 |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | ||||||||||||
Depressive Neuroses | ||||||||||||
DRG 881: DEPRESSIVE NEUROSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
DRG 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cirrhosis And Alcoholic Hepatitis | ||||||||||||
DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peptic Ulcer | ||||||||||||
DRG 380: COMPLICATED PEPTIC ULCER WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Postoperative And Post-Traumatic Infections | ||||||||||||
DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hiv With Major Related Condition | ||||||||||||
DRG 974: HIV WITH MAJOR RELATED CONDITION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Ear,Nose,Mouth And Throat Diagnoses |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 304: HYPERTENSION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Atherosclerosis | ||||||||||||
DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 302: ATHEROSCLEROSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Angina Pectoris | ||||||||||||
DRG 311: ANGINA PECTORIS |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Other Respiratory System Diagnoses | ||||||||||||
DRG 206: OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 205: OTHER RESPIRATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
DRG 207: RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT >96 HOURS | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||
DRG 438: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
DRG 371: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
DRG 444: DISORDERS OF THE BILIARY TRACT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cholecystectomy | ||||||||||||
DRG 417: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
Endocrine Disorders | ||||||||||||
DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Inflammatory Bowel Disease |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Procedures | ||||||||||||
DRG 673: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Nonspecific Cerebrovascular Disorders | ||||||||||||
DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||
DRG 073: CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | ||||||||||||
Major Chest Procedures | ||||||||||||
DRG 163: MAJOR CHEST PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peritoneal Adhesiolysis |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Procedures For Obesity | ||||||||||||
DRG 621: O.R. PROCEDURES FOR OBESITY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 620: O.R. PROCEDURES FOR OBESITY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 619: O.R. PROCEDURES FOR OBESITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Stomach, Esophageal And Duodenal Procedures | ||||||||||||
DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tendonitis, Myositis And Bursitis | ||||||||||||
DRG 557: TENDONITIS, MYOSITIS AND BURSITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
DRG 542: PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Osteomyelitis | ||||||||||||
Connective Tissue Disorders |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Nevada Total Hospitalizations (Oct 2016 to Sep 2019) | Nevada Total Hospitalizations After Exclusion | Nevada Total Users | Nevada Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures |